Trials / Completed
CompletedNCT02917161
Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Dominik Abt · Academic / Other
- Sex
- Male
- Age
- 45 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
MRI findings after successful PAE in patients suffering from BPH suggest a complete necrosis of the prostate after this intervention. Thus, PAE might also play a role in the treatment of prostate cancer. This proof of concept study assess the impact of PAE in patients with proven prostate cancer.
Detailed description
MRI findings after successful PAE in patients suffering from BPH suggest a complete necrosis of the prostate after this intervention. Thus, PAE might also play a role in the treatment of prostate cancer. This proof of concept study assess the impact of PAE in patients with proven prostate cancer. PAE is performed in patients that are planned to undergo robot-assisted laparoscopic prostatectomy for proven localized prostate cancer. The impact of neo-adjuvantly performed PAE on histological tumor regression, surgical margins as well as on safety parameters are assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Prostatic Artery Embolization (PAE) | PAE is performed 6 weeks before radical prostatectomy |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-06-01
- Completion
- 2017-08-03
- First posted
- 2016-09-28
- Last updated
- 2017-08-09
Locations
2 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT02917161. Inclusion in this directory is not an endorsement.